Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10362/142688
Título: | Boosting antimicrobial activity of ciprofloxacin by functionalization of mesoporous silica nanoparticles |
Autor: | Mora, Blanca de Juan Filipe, Luís Forte, Andreia Santos, Miguel M. Alves, Celso Teodoro, Fernando Pedrosa, Rui Carrott, Manuela Ribeiro Branco, Luís C. Gago, Sandra |
Palavras-chave: | Antimicrobial activity Ciprofloxacin Cytotoxicity Ionic liquids Mesoporous silica nanoparticles Pharmaceutical Science |
Data: | 5-Fev-2021 |
Citação: | Mora, B. D. J., Filipe, L., Forte, A., Santos, M. M., Alves, C., Teodoro, F., Pedrosa, R., Carrott, M. R., Branco, L. C., & Gago, S. (2021). Boosting antimicrobial activity of ciprofloxacin by functionalization of mesoporous silica nanoparticles. Pharmaceutics, 13(2), 1-16. Article 218. https://doi.org/10.3390/pharmaceutics13020218 |
Resumo: | Mesoporous silica nanoparticles (MSNs) are very promising nanomaterials for treating bacterial infections when combined with pharmaceutical drugs. Herein, we report the preparation of two nanomaterials based on the immobilization of ciprofloxacin in mesoporous silica nanoparticles, either as the counter-ion of the choline derivative cation (MSN-[Ch][Cip]) or via anchoring on the surface of amino-group modified MSNs via an amide bond (MSN-Cip). Both nanomaterials were characterized by TEM, FTIR and solution1H NMR spectroscopies, elemental analysis, XRD and N2 adsorption at 77 K in order to provide the desired structures. No cytotoxicity from the prepared mesoporous nanoparticles on 3T3 murine fibroblasts was observed. The antimicrobial activity of the nanomaterials was determined against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Klebsiella pneumoniae) bacteria and the results were promising against S. aureus. In the case of B. subtilis, both nanomaterials exhibited higher antimicrobial activity than the precursor [Ch][Cip], and in the case of K. pneumoniae they exhibited higher activity than neutral ciprofloxacin. |
Descrição: | UID/MAR/04292/2020 PEst-C/LA0006/2013 RECI/BBBBQB/0230/2012 MAR-02.01.01-FEAMP-0042–INOVA4AQUA 022161 |
Peer review: | yes |
URI: | http://hdl.handle.net/10362/142688 |
DOI: | https://doi.org/10.3390/pharmaceutics13020218 |
ISSN: | 1999-4923 |
Aparece nas colecções: | FCT: DQ - Artigos em revista internacional com arbitragem científica |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
pharmaceutics_13_00218_v2.pdf | 2,7 MB | Adobe PDF | Ver/Abrir |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.